Margaret Erin Rodgers Schmidt represents clients in complex civil and criminal government investigations, internal investigations—including investigations involving alleged harassment and workplace misconduct, and civil litigation.
Clients rely on Erin to represent them in internal investigations, government investigations, and litigation arising under the False Claims Act, the Anti-Kickback Statute, the Foreign Corrupt Practices Act, the Medicaid Rebate Statute, the Federal Food, Drug, and Cosmetic Act, and various US federal and state civil and criminal fraud statutes. Erin also regularly counsels pharmaceutical, medical device and healthcare clients on the development and oversight of compliance programs and the negotiation, implementation, and monitoring of corporate integrity agreements involving healthcare entities, the US Department of Justice, and the Office of Inspector General (OIG) of the US Department of Health and Human Services (HHS). Erin co-leads the healthcare industry initiative.
Erin has also worked with clients in the media, nonprofit, and healthcare industries to conduct independent internal investigations and advise on remediation of potential workplace issues.
Erin maintains an active pro bono practice. As a child advocate, she represents young clients in dependency proceedings before the Family Division of the Philadelphia Court of Common Pleas. She has also conducted numerous internal investigations for nonprofit clients.
Prior to attending law school, Erin was a researcher on art and cultural property issues for the Presidential Advisory Commission on Holocaust Assets in the United States and a contributor to the report “Plunder and Restitution: The US and Holocaust Victims’ Assets.”
Erin’s representations have included:
Representing a major pharmaceutical company in qui tam litigation involving allegations of scientific/laboratory improprieties.
Representing a major healthcare provider in a government investigation involving allegations related to a charitable patient assistance program.
Representing a major pharmaceutical company in a government investigation involving allegations related to a relationship with a digital health technology services provider.
Representing a major healthcare provider in an investigation involving allegations of potential kickbacks arising from an agreement with another health care provider.
Conducting an independent investigations of workplace allegations within a media organization on behalf of a special committee of the entity’s boards of directors.
Conducting a cultural assessment and investigation of workplace allegations within a university on behalf of a special committee of the university’s boards of directors.
Representing a multinational medical device manufacturer in multiple federal investigations involving allegations related to the Anti-Kickback Statute and the FCPA.
Represented a major medical device company in a criminal and civil investigation of conduct involving alleged violations of the Anti-Kickback Statute and False Claims Act.
Representation of an international medical device company in connection with alleged FCPA violations related to sales and marketing practices in India.
Representing a major pharmaceutical company in a criminal and civil federal investigation related to alleged off-label promotion.
Conducting internal investigations for major pharmaceutical and medical device companies including investigations related to alleged kick-backs, off-label promotion, and reimbursement guidance.
Providing advice to various pharmaceutical and medical device companies regarding robust corporate compliance programs and the negotiation, implementation and monitoring of Corporate Integrity Agreements with the Office of Inspector General (OIG) of the US Department of Health and Human Services.
Representation of a startup pharmaceutical company in an arbitration involving breach of contract claims related to the conduct of a clinical trial.
Representation of a Fortune 50 computer manufacturer in a government investigation.
Representation of a major pharmaceutical company in federal and state government investigations involving the marketing and pricing of products.
Georgetown University Law Center, 2005, J.D., Cum Laude
Loyola College in Maryland, 1999, B.A., Summa Cum Laude, Phi Beta Kappa
U.S. District Court for the Eastern District of Pennsylvania
Awards and Affiliations
Named, Modern Healthcare’s “Largest Healthcare Firm” (2016–2020)
Co-Leader, Morgan Lewis Healthcare Industry Initiative
Co-Leader, ML Women Philadelphia
Co-Chair, Philadelphia Young Lawyers Division of the White Collar Crime Committee
Member, Pennsylvania Bar Association
Staff Editor, Georgetown Journal on Poverty Law & Policy